Nautilus Biotechnology (NAUT) EPS (Diluted) (2020 - 2026)

Nautilus Biotechnology (NAUT) EPS (Diluted) (2020 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Diluted) (Qtr)
1	Vertex Pharmaceuticals	139.40 Bn	131.54 Bn	2.84 Bn	4.31
2	Regeneron Pharmaceuticals	86.13 Bn	78.13 Bn	3.93 Bn	12.23
3	Argenx Se	65.58 Bn	60.40 Bn	1.37 Bn	7.33
4	Moderna	58.23 Bn	53.09 Bn	52.00 Mn	-1.96
5	BeOne Medicines	42.18 Bn	37.08 Bn	1.53 Bn	2.05
6	Alnylam Pharmaceuticals	31.61 Bn	28.30 Bn	992.69 Mn	1.19
7	BioNTech SE	27.97 Bn	9.58 Bn	668.28 Mn	-0.72
8	Insmed	27.55 Bn	26.39 Bn	358.27 Mn	-0.06
9	Royalty Pharma	27.31 Bn	26.47 Bn	-	0.15
10	Nautilus Biotechnology	121.85 Mn	121.85 Mn	175,000.00	-0.11

Download Data